Publication | Closed Access

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction

Hematological MalignancyHaematological DysfunctionMedicineHematologyHistopathologyImmunologyPathologyCytosine ArabinosideBlood CellOncologyMulti-centre Pilot Study